Anti-interleukin-6 receptor antibody treatment ameliorates postoperative adhesion formation

Sci Rep. 2019 Nov 26;9(1):17558. doi: 10.1038/s41598-019-54175-1.

Abstract

Postoperative adhesion formation often ruins the quality of life or is an obstacle to illnesses with curative operation such as cancer. Previously we demonstrated that interferon-γ-promoted fibrin deposition drove postoperative adhesion formation. However, its underlying cellular and molecular mechanisms remain poorly understood. We found that myofibroblasts of the adhesion predominantly expressed signature molecules of mesothelial cells that line the serosa. Microarray analysis revealed IL-6 as a key underlying player, supported by elevated IL-6 levels in the peritoneal fluid of post-laparotomy human subjects. Injured serosa of cecum-cauterized mice also exhibited induction of Il6, which was followed by Tnf, concomitant with rapid accumulation of neutrophils, substantial population of which expressed TGF-β1, a master regulator of fibrosis. Besides, neutrophil-ablated mice showed reduction in induction of the adhesion, suggesting that TGF-β1+neutrophils triggered the adhesion. Human neutrophils expressed TGFB1 in response to TNF-α and TNF in response to IL-6. Moreover, anti-IL-6 receptor monoclonal antibody abrogated neutrophil recruitment and adhesion formation. Thus, IL-6 signaling represents a potential target for the prevention of postoperative adhesions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / immunology
  • Antibodies, Monoclonal / therapeutic use*
  • Ascitic Fluid / chemistry
  • Humans
  • Interleukin-6 / analysis
  • Interleukin-6 / metabolism
  • Mice
  • Mice, Inbred C57BL
  • Myofibroblasts / metabolism
  • Neutrophils / metabolism
  • Postoperative Complications / prevention & control*
  • Receptors, Interleukin-6 / immunology*
  • Receptors, Interleukin-6 / physiology
  • Tissue Adhesions / prevention & control*
  • Transforming Growth Factor beta1 / metabolism
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Antibodies, Monoclonal
  • Interleukin-6
  • Receptors, Interleukin-6
  • Transforming Growth Factor beta1
  • Tumor Necrosis Factor-alpha